2004
AN OVERVIEW OF CHEMOTHERAPY TRIALS IN LOCALIZED AND RECURRENT NONMETASTATIC PROSTATE CANCER
Oh W. AN OVERVIEW OF CHEMOTHERAPY TRIALS IN LOCALIZED AND RECURRENT NONMETASTATIC PROSTATE CANCER. Journal Of Urology 2004, 172: s34-s37. PMID: 15535440, DOI: 10.1097/01.ju.0000141674.92253.fe.Peer-Reviewed Original ResearchConceptsHormone refractory diseaseProstate cancerLocal therapyRefractory diseaseClinical trialsFeasibility of administering chemotherapyProstate cancer disease statesState of prostate cancerHormone refractory prostate cancerHigh riskDefinitive local therapyDefinitive local treatmentStudies evaluating chemotherapyRecurrent prostate cancerLocalized prostate cancerRefractory prostate cancerNonmetastatic prostate cancerPhase III trialsRisk of recurrenceCancer disease statesAndrogen-dependent diseasesMedline literature reviewAntigenic stateRandomized clinical trialsNeoadjuvant setting
2003
The Evolving Role of Chemotherapy and Other Systemic Therapies for Managing Localized Prostate Cancer
Oh W. The Evolving Role of Chemotherapy and Other Systemic Therapies for Managing Localized Prostate Cancer. Journal Of Urology 2003, 170: s28-s34. PMID: 14610407, DOI: 10.1097/01.ju.0000095356.02647.64.Peer-Reviewed Original ResearchConceptsLocalized prostate cancerProstate cancerSystemic therapyLocalized diseaseClinical trialsClinical stage T3 diseaseHigh-risk localized diseaseSerum prostate specific antigenHormone refractory prostate cancerHigh riskBiopsy Gleason scoreStage T3 diseaseStudies evaluating chemotherapyRefractory prostate cancerAdvanced prostate cancerMolecular targeted agentsProstate specific antigenMedline literature reviewNeoadjuvant settingGleason scoreT3 diseaseMetastatic diseaseCytotoxic chemotherapyLocal therapyAdjuvant chemotherapy
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply